LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

Home・Akciju saraksts・IQVIA Holdings Inc

IQVIA Holdings Inc

Slēgts

SektorsVeselības aprūpe

218.03 -2.46

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

217.84

Max

223.49

Galvenie mērījumi
By Trading Economics
Ienākumi	66M 332M
Pārdošana	83M 4.1B
P/E Sektora vidējais	30.752 80.03
Peļņas marža	8.098
Darbinieki	91,000
EBITDA	102M 883M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+7.19% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	586M 38B
Iepriekšējā atvēršanas cena	220.49
Iepriekšējā slēgšanas cena	218.03

Ziņu noskaņojums

By Acuity

30%

70%

166 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

150.68 / 153.45 Atbalsts un pretestība

IQVIA Holdings Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 9. dec. 22:13 UTC

Peļņas

GE Vernova Raises Outlook, Doubles Dividend on Energy Market Momentum

2025. g. 9. dec. 21:40 UTC

Peļņas

GameStop Sales Fall as Collectibles Remain Only Bright Spot

2025. g. 9. dec. 18:51 UTC

Iegādes, apvienošanās, pārņemšana

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

2025. g. 9. dec. 16:57 UTC

Galvenie tirgus virzītāji

Clear Secure Rises on Medicare Identity Verification Contract

2025. g. 9. dec. 23:46 UTC

Tirgus saruna

Nikkei May Trade Rangebound Ahead of Fed Rate Decision -- Market Talk

2025. g. 9. dec. 23:46 UTC

Iegādes, apvienošanās, pārņemšana

Legend Holdings Stake in Lenovo Now at 32.34%

2025. g. 9. dec. 23:45 UTC

Iegādes, apvienošanās, pārņemšana

Legend Holdings: Remains Optimistic About Lenovo's Future Development Potential

2025. g. 9. dec. 23:44 UTC

Iegādes, apvienošanās, pārņemšana

Legend Holdings: Purchased Lenovo Shares at Average Price of HK$9.7653/Share

2025. g. 9. dec. 23:43 UTC

Iegādes, apvienošanās, pārņemšana

Legend Holdings: Acquired Lenovo Shares for Total Cash Consideration of HK$1.12B

2025. g. 9. dec. 23:43 UTC

Iegādes, apvienošanās, pārņemšana

Legend Holdings: Acquired 115.17M Lenovo Shares From Open Market Between Nov. 21 and Dec. 9

2025. g. 9. dec. 23:35 UTC

Tirgus saruna

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

2025. g. 9. dec. 22:42 UTC

Peļņas

PepsiCo Wants to Boost Sales, Cut Costs. The Street Is Doubtful. -- Barrons.com

2025. g. 9. dec. 21:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 9. dec. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 9. dec. 21:48 UTC

Tirgus saruna

Hiring Confidence Slips in Canada Entering 2026 -- Market Talk

2025. g. 9. dec. 21:36 UTC

Peļņas

Casey's General Stores: Fiscal 2026 EBITDA Is Expected to Increase 15% to 17% >CASY

2025. g. 9. dec. 21:36 UTC

Peļņas

Casey's General Stores: Total Inside Gross Profit Increased 13.5% to $703.4M Compared to Prior Yr >CASY

2025. g. 9. dec. 21:36 UTC

Peļņas

Casey's General Stores: Now Expects Inside Same-Store Sales to Increase 3% to 4% and an Inside Margin of 41% to 42% >CASY

2025. g. 9. dec. 21:36 UTC

Peļņas

Casey's General Stores: Same-Store Fuel Gallons Up 0.8% Compared to Prior Yr With Fuel Margin of 41.6 Cents per Gallon, Total Fuel Gross Profit Increased 20.9% to $377.4M Compared to Prior Yr >CASY

2025. g. 9. dec. 21:36 UTC

Peļņas

Casey's General Stores: Inside Same-Store Sales Increased 3.3% Compared to Prior Yr, and 7.5% on 2-Yr Stack Basis, With an Inside Margin of 42.4% >CASY

2025. g. 9. dec. 20:28 UTC

Tirgus saruna

Oil Futures Decline for Second Straight Session -- Market Talk

2025. g. 9. dec. 20:27 UTC

Iegādes, apvienošanās, pārņemšana

Teck Resources: Merger of Equals With Anglo Amer Plc Approved by Both Classes of Teck Hldrs

2025. g. 9. dec. 20:27 UTC

Iegādes, apvienošanās, pārņemšana

Teck Reports Voting Results From Special Meeting of Hldrs

2025. g. 9. dec. 20:26 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Moody's: Paramount's Warner Bid Makes Strategic Sense, With Risk -- Market Talk

2025. g. 9. dec. 20:21 UTC

Tirgus saruna

U.S. Natural Gas Extends Pullback on Shifting Weather Outlook -- Market Talk

2025. g. 9. dec. 19:52 UTC

Peļņas

Correction to 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com on Dec. 8

2025. g. 9. dec. 19:17 UTC

Peļņas

Update: 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com

2025. g. 9. dec. 17:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 9. dec. 17:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 9. dec. 17:11 UTC

Peļņas

Nvidia Has Permission to Sell H200 Chips to China. Why It Might Not Matter Much for the Stock. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

IQVIA Holdings Inc Prognoze

Cenas mērķis

By TipRanks

7.19% augšup

Prognoze 12 mēnešiem

Vidējais 239.64 USD 7.19%

Augstākais 265 USD

Zemākais 200 USD

Pamatojoties uz 16 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi IQVIA Holdings Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

16 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 16 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam IQVIA Holdings Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

150.68 / 153.45Atbalsts un pretestība

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bearish.

Noskaņojums

By Acuity

166 / 374 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.